Gut Microbiome Clinical Trial
— NEOBIFIOfficial title:
Effects of an Association of the Two Bifidobacteria Probiotics Bifidobacterium Breve B632 and Bifidobacterium Breve BR03 in Intestinal Bacterial Colonization and in the Prevention and/or Reduction of the Incidence of Colics in Infants
Verified date | January 2018 |
Source | Azienda Ospedaliero Universitaria Maggiore della Carita |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Infant colics represent a clinical condition in childhood, characterized by an uncontrollable
crying that occurs without any apparent organic cause.1 They can be associated with face
redness, closed fists, thighs flexion, meteorism, and gas emission. They are generally
diagnosed according to Wessel's "rule of three" (>3 h of crying a day, for >3d a week, for
>3wk in a row).2 These crises tend to reach their maximum intensity at 6 weeks of age, in
most cases.3 They represent a serious source of anxiety for the family, increasing hospital
admissions (5.8% of infants),4 postpartum depression risk, with higher stress levels for up
to 3 years from these events. The etiology is still unknown. Anyway, it's assumed that the
following factors may be involved: (1) Lactose intolerance. (2) Food hypersensitivity. (3)
Feeding difficulties. (4) Disorders of the enteric nervous system. (5) Alterations of pain
transmission. (6) Gastroesophageal reflux. (7) Intestinal hormones. (8) Psychosocial factors.
(9) Alteration of the intestinal microbiota. In 1994, Lehtonen was the first to suggest that
an altered intestinal microbiota composition in the very first months may induce intestinal
colics in infants. Human intestinal microbiota is composed of about 1013 to 1014
microorganisms, mainly bacteria. The total number of microbiota genes is called "microbioma"
and it is estimated to be 150 times the number of genes in the human genome.5 It acts as a
real organ, whose activity can be influenced by diet, lifestyle, prebiotics, probiotics, and
antibiotics. Several studies revealed the predominance of bifidobacteria in breastfed
infants, whereas bottle-fed infants show a mixed population where bifidobacteria are less
represented. the intestinal microbiota composition in a 3-year-old child is already similar
to that of an adult.6 Other factors conditioning the microbiota are gestational age and type
of birth. Colicky infants have a microbiota with a slow development and a lower stability
over time.7 It also contains less lactobacilli and bifidobacteria, and a prevalence of
gram-negative bacteria. The stools of these children often show increased levels of
calprotectin, an intestinal index of inflammation.
RISK FACTORS ARE SEVERAL: Smoking: The exposure to cigarette smoke may be related to colics;
this might be connected to the increase of plasma and intestinal levels of motilin. Maternal
smoking during pregnancy seems to increase the risk of developing colics, more than postnatal
exposition to smoke.8
Psychosocial: Infant colics may be more frequent with an instable psychosocial family
environment. Maternal stress, anxiety, and depression are important risk factors.8
Breastfeeding: The difference between breastfeeding and bottlefeeding for colicky infants is
controversial. Many studies have shown contrasting results,17 but the majority of the authors
agree to attribute an important role to bottlefeeding. 9 A melatonin role was assumed too.
This hormone is not secreted in infants, but only in adults, and has a hypnotic and relaxing
role on the gastrointestinal smooth muscle. Its concentration shows a clear circadian rhythm,
with a pick during night hours. Its presence in breast milk may be related to the lower
occurrence of colics in breastfed infants compared with the bottle-fed infants.9 Recent
literature shows an increasing attention toward probiotics,10 for the intestinal microbiota
modulation. Some Lactobacillus reuteri strains were studied, with contrasting results in
different studies; other probiotics as bifidobacteria showed in vitro anti-inflammatory
properties and the ability to inhibit coliforms growth, whose presence is significant in
colicky infants. Some probiotics exert a direct action on the bacterial growth, through
bacteriocins production and final fermentation products.11 Bifidobacterium breve was isolated
from healthy infants' feces.12 Aloisio et al13 tested in vitro ability of this strain and of
other 45 bifidobacteria strains to oppose the growth of several microorganisms such as E.
coli, S. enteriditis, C. difficile, K. pneumoniae, and Enterobacter cloacae. B. breve BR03,
in a randomized clinical study, proved to have a beneficial effect on constipation in adults,
it also seemed effective for the reduction of gas formation and for abdominal distension, and
no side effects were shown during the treatment, while the beneficial effects lasted for up
to 15 days after the end of the treatment.14,15 Both bifidobacteria strains showed, during an
in vitro study, the ability to oppose 4 strains of E. coli; in particular, BR03 displayed an
activity against E. coli O157:H7, an enterohemorrhagic strain that through Shiga toxin causes
a potentially lethal infection.16
Status | Completed |
Enrollment | 320 |
Est. completion date | July 31, 2017 |
Est. primary completion date | July 31, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A to 15 Days |
Eligibility |
Inclusion Criteria: - Only healthy babies term born - Between 6 days and 15 days of life - With a Birth weight between 2500 gr and 4000 gr - With natural childbirth Exclusion Criteria: - Adverse reactions to the product or component of the product (allergies…) - Antibiotic treatments - Chronic diseases, hepatic or gastroenterological diseases - Medical treatment for chronic diseases - Probiotic or prebiotic therapies |
Country | Name | City | State |
---|---|---|---|
Italy | AOU Maggiore della Carità - Clinica Pediatrica - Ambulatorio di Gastroenterologia Pediatrica | Novara |
Lead Sponsor | Collaborator |
---|---|
Azienda Ospedaliero Universitaria Maggiore della Carita |
Italy,
Aloisio I, Santini C, Biavati B, Dinelli G, Cencic A, Chingwaru W, Mogna L, Di Gioia D. Characterization of Bifidobacterium spp. strains for the treatment of enteric disorders in newborns. Appl Microbiol Biotechnol. 2012 Dec;96(6):1561-76. doi: 10.1007/s00253-012-4138-5. Epub 2012 May 17. — View Citation
Brooks GF, Carroll KC, Butel JS, et al. Jawetz, Melnick, & Adelberg's Medical Microbiology, 26e. Columbus, OH: McGraw-Hill; 2013.
Cohen Engler A, Hadash A, Shehadeh N, Pillar G. Breastfeeding may improve nocturnal sleep and reduce infantile colic: potential role of breast milk melatonin. Eur J Pediatr. 2012 Apr;171(4):729-32. doi: 10.1007/s00431-011-1659-3. Epub 2011 Dec 29. — View Citation
de Weerth C, Fuentes S, Puylaert P, de Vos WM. Intestinal microbiota of infants with colic: development and specific signatures. Pediatrics. 2013 Feb;131(2):e550-8. doi: 10.1542/peds.2012-1449. Epub 2013 Jan 14. — View Citation
Del Piano M, Carmagnola S, Anderloni A, Andorno S, Ballarè M, Balzarini M, Montino F, Orsello M, Pagliarulo M, Sartori M, Tari R, Sforza F, Capurso L. The use of probiotics in healthy volunteers with evacuation disorders and hard stools: a double-blind, randomized, placebo-controlled study. J Clin Gastroenterol. 2010 Sep;44 Suppl 1:S30-4. doi: 10.1097/MCG.0b013e3181ee31c3. — View Citation
Iacono G, Merolla R, D'Amico D, Bonci E, Cavataio F, Di Prima L, Scalici C, Indinnimeo L, Averna MR, Carroccio A; Paediatric Study Group on Gastrointestinal Symptoms in Infancy. Gastrointestinal symptoms in infancy: a population-based prospective study. Dig Liver Dis. 2005 Jun;37(6):432-8. Epub 2005 Mar 2. — View Citation
Iemoli E, Trabattoni D, Parisotto S, Borgonovo L, Toscano M, Rizzardini G, Clerici M, Ricci E, Fusi A, De Vecchi E, Piconi S, Drago L. Probiotics reduce gut microbial translocation and improve adult atopic dermatitis. J Clin Gastroenterol. 2012 Oct;46 Suppl:S33-40. doi: 10.1097/MCG.0b013e31826a8468. — View Citation
Indrio F, Di Mauro A, Riezzo G, Civardi E, Intini C, Corvaglia L, Ballardini E, Bisceglia M, Cinquetti M, Brazzoduro E, Del Vecchio A, Tafuri S, Francavilla R. Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial. JAMA Pediatr. 2014 Mar;168(3):228-33. doi: 10.1001/jamapediatrics.2013.4367. — View Citation
Kheir AE. Infantile colic, facts and fiction. Ital J Pediatr. 2012 Jul 23;38:34. doi: 10.1186/1824-7288-38-34. Review. Retraction in: Ital J Pediatr. 2014;40(1):9. — View Citation
Mogna L, Del Piano M, Deidda F, Nicola S, Soattini L, Debiaggi R, Sforza F, Strozzi G, Mogna G. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains. J Clin Gastroenterol. 2012 Oct;46 Suppl:S29-32. doi: 10.1097/MCG.0b013e31826852b7. — View Citation
Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Doré J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J; MetaHIT Consortium, Bork P, Ehrlich SD, Wang J. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010 Mar 4;464(7285):59-65. doi: 10.1038/nature08821. — View Citation
Rhoads JM, Fatheree NY, Norori J, Liu Y, Lucke JF, Tyson JE, Ferris MJ. Altered fecal microflora and increased fecal calprotectin in infants with colic. J Pediatr. 2009 Dec;155(6):823-828.e1. doi: 10.1016/j.jpeds.2009.05.012. Epub 2009 Jul 22. — View Citation
Roger LC, Costabile A, Holland DT, Hoyles L, McCartney AL. Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life. Microbiology. 2010 Nov;156(Pt 11):3329-41. doi: 10.1099/mic.0.043224-0. Epub 2010 Sep 23. — View Citation
Sanders ME. Impact of probiotics on colonizing microbiota of the gut. J Clin Gastroenterol. 2011 Nov;45 Suppl:S115-9. doi: 10.1097/MCG.0b013e318227414a. Review. — View Citation
Savino F, Cordisco L, Tarasco V, Calabrese R, Palumeri E, Matteuzzi D. Molecular identification of coliform bacteria from colicky breastfed infants. Acta Paediatr. 2009 Oct;98(10):1582-8. doi: 10.1111/j.1651-2227.2009.01419.x. Epub 2009 Jul 9. — View Citation
Savino F, Cordisco L, Tarasco V, Palumeri E, Calabrese R, Oggero R, Roos S, Matteuzzi D. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics. 2010 Sep;126(3):e526-33. doi: 10.1542/peds.2010-0433. Epub 2010 Aug 16. — View Citation
Savino F. Focus on infantile colic. Acta Paediatr. 2007 Sep;96(9):1259-64. Review. — View Citation
Scardovi V, Casalicchio F, Vincenzi N. Multiple electrophoretic forms of transaldolase and 6-phosphogluconic dehydrogenase and their relationships to the taxonomy and ecology of the bifidobacteria. Int J Syst Bacteriol. 1979;29:312-327.
Sung V, Hiscock H, Tang ML, Mensah FK, Nation ML, Satzke C, Heine RG, Stock A, Barr RG, Wake M. Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial. BMJ. 2014 Apr 1;348:g2107. doi: 10.1136/bmj.g2107. — View Citation
Van Niel CW. Probiotics: not just for treatment anymore. Pediatrics. 2005 Jan;115(1):174-7. — View Citation
WESSEL MA, COBB JC, JACKSON EB, HARRIS GS Jr, DETWILER AC. Paroxysmal fussing in infancy, sometimes called colic. Pediatrics. 1954 Nov;14(5):421-35. — View Citation
WHO. WHO European Ministerial Conference on Nutrition and Noncommunicable Diseases in the Context of Health 2020. Vienna: WHO; 2013.
Yalçin SS, Orün E, Mutlu B, Madendag Y, Sinici I, Dursun A, Ozkara HA, Ustünyurt Z, Kutluk S, Yurdakök K. Why are they having infant colic? A nested case-control study. Paediatr Perinat Epidemiol. 2010 Nov;24(6):584-96. doi: 10.1111/j.1365-3016.2010.01150.x. Epub 2010 Aug 17. — View Citation
* Note: There are 23 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in infants crying - reduction of infants crying | The primary endpoint of the study was the assessment of the effectiveness of B. breve B632 and BR03 association in the reduction of infants crying over time. Both breastfed and bottle-fed babies were studied. | Change from Baseline (V0) of infant crying at 3 months (V1) | |
Secondary | Change in gastrointestinal symptoms | The second endpoint was to observe the effect of these probiotics on daily evacuations and on the number of regurgitations and vomits. | Change from Baseline (V0) of fecal evacuations, regurgitations and vomits at 3 months (V1) | |
Secondary | Change in fecal microbiome | Evaluate any variation of fecal microbiome | Change from Baseline of fecal microbiome (V0) at 3 months (V1) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05793112 -
INF108F in Infants With Food Protein Induced Proctocolitis
|
Phase 4 | |
Active, not recruiting |
NCT04327141 -
Low Sugar Protein Pacing, Intermittent Fasting Diet in Men and Women
|
N/A | |
Recruiting |
NCT04117321 -
Mother-infant Microbiota Transmission and Its Link to the Health of the Baby
|
||
Recruiting |
NCT05655910 -
Enhanced Nutritional Optimization in LVAD Trial
|
N/A | |
Recruiting |
NCT03325855 -
Fecal Microbiota Transplant National Registry
|
||
Active, not recruiting |
NCT05931471 -
Yogurt and GI Health
|
N/A | |
Recruiting |
NCT03797417 -
Gut Microbiome and Metabolic Pathways Changes in Vitiligo
|
||
Withdrawn |
NCT06006416 -
Effect of Fenugreek Fibre on Gut Microbiome
|
Phase 3 | |
Recruiting |
NCT06206486 -
The Gut Microbiome and Serum Metabolites as a Biological Mechanism Underlying Pain in Kidney Transplantation
|
||
Completed |
NCT02655250 -
Neonatal Microbiome Validity Study
|
||
Recruiting |
NCT05670288 -
Impact of Gut Microbiome on Metabolic and Bowel Function During the First Year After Spinal Cord Injury
|
||
Not yet recruiting |
NCT03975764 -
Fecal Microbiota in Preterm Birth
|
||
Recruiting |
NCT04447365 -
The Correlation Between Gut Microbiome-host Interaction and Ventricular Arrhythmias.
|
||
Recruiting |
NCT04466072 -
Gut Microbiome and Ventricular Arrhythmias
|
||
Not yet recruiting |
NCT06130137 -
Gut Microbiome in People Living With HIV and HBV
|
||
Recruiting |
NCT06260579 -
Home-based Exercise and Physical Activity Intervention After Kidney Transplantation: Impact of Exercise Intensity
|
N/A | |
Completed |
NCT04511052 -
Probiotics for Enhanced Tissue Carotenoid Status in Premenopausal Women
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT06424691 -
Infant Restore: Efficacy of Microbiome Analysis and Education
|
N/A | |
Recruiting |
NCT06404749 -
Fungal Fiber for Gut Health
|
N/A | |
Not yet recruiting |
NCT06433310 -
Understanding the Efficacy of Dietary Supplement on Fungal Mycobiota in Healthy Volunteers: A Pilot Study
|
Early Phase 1 |